炎症性腸疾患に関連した主な遺伝因子と腸の透過性への影響:腸の炎症への関与
PubMedで要約を見る
まとめ
この要約は機械生成です。クローン病や 潰瘍性大腸炎のような 炎症性腸疾患 (IBD) は 遺伝的要因や 環境要因が関係しています このレビューでは,主要なIBD経路に関連した腸の透過性の変化が 慢性炎症にどのように寄与するかを調査します.
科学分野
- 胃腸内科と免疫学
背景
- クローン病 (CD) や潰瘍性大腸炎 (UC) を含む炎症性腸疾患 (IBD) は,慢性胃腸疾患である.
- IBDの病原性には 遺伝的傾向と環境要因の 複雑な相互作用が関係しています
- 200以上のIBD感受性の位置が特定され,重要な生物学的経路が関与しています.
研究 の 目的
- IBDに関連した主要な経路と腸の透過性の変化を結びつける分子と細胞のメカニズムを見直す.
- これらの変化がIBDにおける慢性炎症の発症と悪化にどのように寄与するか解明する.
主な方法
- IBDの遺伝学,病理生理学,腸の浸透性に関する既存の文献のレビュー.
- IBD に関する主要な経路の分析:細菌の感知,オートファジー,内分泌網膜のストレス,Th-17免疫,ビタミンDの信号伝達.
- IBD 発症と予後における腸の浸透性の増加の役割の検討
主要な成果
- IBDでは5つの主要な経路が一貫して変化します. NOD2 (バクテリア感知),オートファジー,内分泌網膜ストレス,IL23受容体 (Th-17経路),およびVDR (ビタミンD受容体).
- 腸内浸透性の増加は,CDの発症前の認識された特徴であり,静止性IBDの再発の予後指標として機能する.
- これらの経路は,腸内微生物群に対する異常な免疫反応に寄与し,腸内浸透性の増加に起因する.
結論
- 慢性炎症を促進するIBDの病原性の重要な要因です.
- IBD経路と漏れ性腸を結びつける 分子メカニズムを理解することは 標的治療の開発に不可欠です
- 腸の浸透性の向上は,IBDの管理と疾患の再発の予防のための潜在的な治療目標です.
関連する概念動画
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

